Similarly, anti-CD20 opsonized tumor cells promote CD16 clearance from NK cell surface followed by a dramatic reduction of ADCC (Capuano et al., 2015; Capuano et al., 2017). The gene discussed is FCGR3A; the disease is neoplasm.